Clinical trial
Combination Chemotherapy in Treating Patients With Advanced Cancer
NCT00003956 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003956 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Advanced Cancer |
| Official title | A Phase I Study of Continuous Oral Administration of SCH 66336 and 5-Fluorouracil/Leucovorin (5FU/LV) in Patients With Advanced Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | fluorouracil, leucovorin calcium, lonafarnib |
| Enrollment | 25 |
| Start date | Apr 1, 1999 |
| Primary completion | Jan 1, 2001 |
| Completion | Dec 1, 2009 |
| First posted | Sep 14, 2004 |
| Last update posted | Apr 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: